Insider Transactions in Q4 2021 at Steris PLC (STE)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 23
2021
|
Michael J Tokich Sr. Vice Pres., CFO |
SELL
Open market or private sale
|
Direct |
30,000
-39.24%
|
$7,200,000
$240.0 P/Share
|
|
Dec 23
2021
|
Michael J Tokich Sr. Vice Pres., CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+28.18%
|
$2,070,000
$69.72 P/Share
|
|
Dec 02
2021
|
Andrew Xilas SVP and GM, Dental |
SELL
Payment of exercise price or tax liability
|
Direct |
126
-5.03%
|
$27,720
$220.63 P/Share
|
|
Dec 02
2021
|
Andrew Xilas SVP and GM, Dental |
BUY
Exercise of conversion of derivative security
|
Direct |
333
+11.73%
|
-
|
|
Nov 15
2021
|
Cary L Majors SVP and President, Healthcare |
SELL
Open market or private sale
|
Direct |
1,950
-13.31%
|
$452,400
$232.97 P/Share
|
|
Oct 22
2021
|
Michael J Tokich Sr. Vice Pres., CFO |
SELL
Open market or private sale
|
Direct |
20,000
-30.1%
|
$4,700,000
$235.0 P/Share
|
|
Oct 22
2021
|
Michael J Tokich Sr. Vice Pres., CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+23.14%
|
$1,340,000
$67.98 P/Share
|
|
Oct 11
2021
|
Andrew Xilas SVP and GM, Dental |
SELL
Payment of exercise price or tax liability
|
Direct |
149
-6.42%
|
$32,929
$221.54 P/Share
|
|
Oct 11
2021
|
Andrew Xilas SVP and GM, Dental |
BUY
Exercise of conversion of derivative security
|
Direct |
506
+17.89%
|
-
|
|
Oct 07
2021
|
Andrew Xilas SVP and GM, Dental |
SELL
Payment of exercise price or tax liability
|
Direct |
179
-8.97%
|
$38,843
$217.33 P/Share
|
|
Oct 07
2021
|
Andrew Xilas SVP and GM, Dental |
BUY
Exercise of conversion of derivative security
|
Direct |
607
+23.33%
|
-
|
|
Oct 01
2021
|
Karen L Burton VP & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
344
+5.12%
|
-
|
|
Oct 01
2021
|
Daniel A Carestio President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,156
+3.5%
|
-
|
|
Oct 01
2021
|
Mary Clare Fraser SVP & Chief HRO |
BUY
Grant, award, or other acquisition
|
Direct |
692
+11.25%
|
-
|
|
Oct 01
2021
|
Julia Madsen Sr. VP and GM, Life Sciences |
SELL
Sale (or disposition) back to the issuer
|
Direct |
121
-1.88%
|
$27,588
$228.36 P/Share
|
|
Oct 01
2021
|
Julia Madsen Sr. VP and GM, Life Sciences |
BUY
Grant, award, or other acquisition
|
Direct |
576
+8.22%
|
-
|
|
Oct 01
2021
|
Cary L Majors SVP and President, Healthcare |
BUY
Grant, award, or other acquisition
|
Direct |
692
+4.51%
|
-
|
|
Oct 01
2021
|
Renato Tamaro V.P. & Corporate Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
344
+5.68%
|
-
|
|
Oct 01
2021
|
Michael J Tokich Sr. Vice Pres., CFO |
BUY
Grant, award, or other acquisition
|
Direct |
576
+1.23%
|
-
|
|
Oct 01
2021
|
Andrew Xilas SVP and GM, Dental |
BUY
Grant, award, or other acquisition
|
Direct |
1,156
+45.44%
|
-
|
|
Oct 01
2021
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
808
+2.54%
|
-
|